Men can absolutely take spironolactone, and millions do. It is one of the most widely prescribed medications for heart failure, resistant hypertension, and fluid retention from liver disease. The reason the question comes up at all is that spironolactone has a well-known antiandrogenic side effect: it blocks testosterone at the receptor level, which can cause breast tissue growth, decreased sex drive, and other hormonal changes in men. These effects are dose-dependent and often manageable, but they make the drug a topic worth understanding before starting it.
Why Men Are Prescribed Spironolactone
Spironolactone is classified as a potassium-sparing diuretic and aldosterone antagonist. Its primary job is blocking aldosterone, a hormone that tells your kidneys to hold onto sodium and water. By blocking aldosterone, spironolactone helps your body shed excess fluid and lowers blood pressure. That mechanism makes it useful for several conditions that are common in men.
Heart failure is probably the biggest reason men end up on spironolactone. In patients with heart failure and resistant hypertension, spironolactone significantly reduced the risk of major cardiac events compared to placebo, with roughly a 30% lower risk in one large analysis.1Journal of the American Heart Association. Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension Blood pressure control improved quickly too: in one trial, about 63% of patients on spironolactone had their blood pressure under control within four weeks, compared to 46% on placebo.2American Journal of Hypertension. Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction The drug has been established as the most effective add-on therapy for resistant hypertension, meaning high blood pressure that does not respond well to the usual first-line medications.3PubMed. Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
Liver cirrhosis with ascites is another common indication. When the liver fails, fluid accumulates in the abdomen, and spironolactone is the initial drug of choice for managing that fluid. Clinical guidelines recommend starting at 100 mg per day, increasing up to 400 mg per day if needed, often with a loop diuretic like furosemide added later.4PubMed Central. Guidelines on the management of ascites in cirrhosis Since liver disease is substantially more common in men, this is a scenario where male patients encounter spironolactone regularly.
How the Antiandrogenic Effect Works
Here is the part that makes spironolactone tricky for men. The drug does not just block aldosterone. It also blocks dihydrotestosterone (DHT), the potent form of testosterone, from binding to androgen receptors throughout the body. Research going back to the 1970s showed that spironolactone inhibits the binding of DHT to androgen receptors in tissue, and that this effect occurs at the same doses used for its blood pressure and fluid-retention benefits.5PubMed. Antiandrogenic effect of spirolactones: mechanism of action In other words, the antiandrogenic effect is not a rare side effect that shows up only at extreme doses. It is baked into the pharmacology of the drug at therapeutic levels.
This dual action is exactly why spironolactone is prescribed deliberately for its antiandrogen properties in other contexts, such as treating hormonal acne and hair loss in women, or as part of feminizing hormone therapy for transgender women. But for a man taking it for heart failure or blood pressure, that same antiandrogen activity is an unwanted passenger.
Side Effects That Affect Men Specifically
The side effects men worry about most are the hormonal ones, and those concerns are legitimate. Spironolactone therapy is often associated with gynecomastia (breast tissue growth) and sexual dysfunction, including reduced libido and erectile difficulties.6PubMed. Spironolactone and endocrine dysfunction The breast changes can be tender or outright painful. In one documented case, a 52-year-old man developed painful swelling in one breast after 12 months on spironolactone; the pain subsided within a month of stopping the drug, with the swelling gradually decreasing after that.7PubMed Central. Spironolactone-Induced Unilateral Gynecomastia
What is interesting is that the hormonal picture is not as straightforward as “spironolactone lowers testosterone.” When healthy male volunteers took 400 mg per day for five days, researchers found a rise in progesterone and 17-alpha-hydroxyprogesterone, but no change in testosterone, estradiol, or prolactin levels.8PubMed. Effect of spironolactone on sex hormones in man The researchers themselves noted that these results did not fully explain the libido changes, impotence, and gynecomastia that frequently show up in men on the drug.9The Journal of Clinical Endocrinology & Metabolism. Effect of Spironolactone on Sex Hormones in Man The leading explanation is that the receptor-blocking effect at the tissue level matters more than what circulating hormone levels look like on a blood test. Your testosterone level might look normal, but if spironolactone is sitting in the receptor where DHT would normally bind, the downstream effects of testosterone are still blunted.
These sexual side effects were actually recognized as a problem from the very beginning. When spironolactone was first developed in 1957, the dose-dependent sexual side effects limited its long-term use, and that recognition eventually spurred the development of more selective alternatives.10PubMed. The 45-year story of the development of an anti-aldosterone more specific than spironolactone
Does Spironolactone Affect Male Fertility?
Fertility is a separate concern from sexual function, and the evidence here is thinner than many patients expect. Animal studies in rats showed that spironolactone reduced sperm concentration in the epididymis by about 22%, but the sperm that remained were still capable of initiating motility and achieving fertilization. The researchers concluded that sperm fertility capacity was “rather resistant” to the drug’s effects.11PubMed. Effects of spironolactone (aldosterone antagonist) on electrolyte and water content of the cauda epididymidis and fertility of male rats In humans, the evidence is limited to a few case reports and small studies suggesting negative effects on fertility, but nothing approaching large-scale proof.12PubMed. Dermatological medication effects on male fertility
If you are a man of reproductive age starting spironolactone and you are concerned about fertility, it is worth raising the issue with your prescriber. The honest answer is that we do not have strong human data proving spironolactone significantly impairs male fertility, but the theoretical concern is plausible given the drug’s antiandrogen mechanism, and there is enough scattered evidence to make it a reasonable conversation.
Hyperkalemia and Why Monitoring Matters
The most medically dangerous risk of spironolactone is not the hormonal stuff. It is hyperkalemia, or high potassium levels in the blood. Because spironolactone stops your kidneys from excreting potassium the way they normally would, potassium can build up, and dangerously high potassium causes cardiac arrhythmias that can be fatal.
The risk is manageable with proper monitoring, but real-world data shows that monitoring does not always happen as it should. One study found that about a third of patients starting spironolactone did not have their potassium or creatinine checked within three months of beginning therapy.13PubMed. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure Another analysis of ambulatory patients found that roughly three-quarters received recommended lab monitoring, with the rate being somewhat higher for older patients, men, people with diabetes, and those on additional drugs that also raise potassium.14Annals of Pharmacotherapy. Laboratory Evaluation of Potassium and Creatinine Among Ambulatory Patients Prescribed Spironolactone: Are We Monitoring for Hyperkalemia?
The risk goes up sharply when spironolactone is combined with ACE inhibitors or angiotensin receptor blockers, which are extremely common in heart failure treatment. In heart failure patients, the combined use of spironolactone with ACE inhibitors or ARBs was associated with a dramatically elevated risk of hyperkalemia, with odds ratios above 11 in real-world data, which is substantially higher than what clinical trials suggested.15Pharmacoepidemiology and Drug Safety. Risk of hyperkalemia and combined use of spironolactone and long‐term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real‐life data The reason for the gap between trial data and real-world data is that clinical trials exclude the sickest patients and enforce strict monitoring protocols. In everyday practice, patients are older, sicker, and less consistently monitored.
That said, the picture is not universally grim. A longitudinal study in Scotland tracked what happened after the landmark RALES heart failure trial in 1999, which led to a surge in spironolactone prescribing. Despite a massive increase in use, rates of outpatient-measured high potassium actually did not climb, and hospital admissions for hyperkalemia remained low. The researchers attributed this to careful monitoring practices adopted alongside the increased prescribing.16BMJ. Spironolactone use and renal toxicity: population based longitudinal analysis The takeaway: hyperkalemia is a real risk, but if your doctor is checking your labs regularly, especially in the first few months and whenever doses change, the drug can be used safely.
Dietary Traps to Watch For
One practical detail that patients often miss: because spironolactone causes your body to retain potassium, anything else that adds potassium to your system compounds the risk. The most common offender is potassium-based salt substitutes, which many people use when told to cut back on sodium. Two documented cases of severe hyperkalemia with serious cardiac arrhythmias occurred when patients on spironolactone used potassium-containing salt substitutes excessively, while also having impaired kidney function.17JAMA. Hyperkalemia With Cardiac Arrhythmia: Induction by Salt Substitutes, Spironolactone, and Azotemia Potassium-enriched salt substitutes carry a known risk of hyperkalemia and its consequences, especially in people whose potassium excretion is already impaired.18Hypertension. Potassium-Enriched Salt Substitutes as a Means to Lower Blood Pressure
Beyond salt substitutes, high-potassium foods like bananas, oranges, potatoes, and spinach do not need to be eliminated, but it is worth being aware of your overall intake, especially if your kidney function is reduced. Your doctor should provide guidance on dietary potassium based on your lab results. The general advice is not to panic about individual foods but to avoid stacking multiple potassium-heavy sources in the same meal while also using a salt substitute.
Drug Interactions Worth Knowing About
If you are a man on spironolactone for heart failure, you may also be on digoxin. This combination deserves attention. Spironolactone reduces the kidney’s ability to clear digoxin from the body and also blunts digoxin’s effect on heart muscle contraction.19PubMed. Interactions between digoxin and potassium-sparing diuretics Potassium-sparing diuretics in general can alter digoxin’s behavior in the body.20PubMed. Pharmacokinetic interactions between digoxin and other drugs Because digoxin has a narrow therapeutic window (the difference between an effective dose and a toxic dose is small), changes in how quickly your body eliminates it can push levels into a dangerous range. If you are taking both, your prescriber should be monitoring digoxin levels along with your potassium and kidney function.
Eplerenone as an Alternative for Men
Eplerenone was developed specifically to solve the sexual side-effect problem. It is a more selective aldosterone blocker: it does the same job on the heart and kidneys without meaningfully blocking androgen receptors. That selectivity translates directly into fewer hormonal side effects. A meta-analysis comparing the two drugs found that eplerenone had a dramatically lower risk of gynecomastia than spironolactone, along with fewer treatment withdrawals overall.21PubMed Central. Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis For men with cirrhosis who develop painful gynecomastia on spironolactone, switching to eplerenone has been shown to reverse the pain and appears to be a safe and clinically acceptable option.22PubMed Central. Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics
So why is not everyone just put on eplerenone instead? Cost is the main barrier. Eplerenone is significantly more expensive, and spironolactone remains the first-line choice in most guidelines for resistant hypertension because of its robust clinical evidence and low price. In practice, the typical approach is to start with spironolactone and switch to eplerenone if hormonal side effects become intolerable. If you are a man who has developed breast tenderness or sexual side effects on spironolactone, asking your doctor about an eplerenone switch is a reasonable and well-supported move.
Topical Spironolactone for Hair Loss
One area where spironolactone is gaining ground for men specifically is topical use for androgenetic alopecia, or pattern hair loss. Because the antiandrogenic effect of spironolactone is exactly what you want at the hair follicle (DHT is the hormone responsible for miniaturizing hair follicles), applying it directly to the scalp seems like a logical workaround for the systemic side effects. And the early evidence supports this idea. A systematic review found that both oral and topical spironolactone showed effectiveness for hair regrowth, but topical application had significantly fewer side effects and was considered suitable for any gender.23PubMed Central. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
The key advantage is that topical spironolactone stays local. Research on men using it on the skin found no changes in circulating hormone levels and no detectable levels of the drug’s active metabolite in the blood, suggesting the drug stays in the skin rather than reaching the rest of the body.24PubMed. Lack of endocrine systemic side effects after topical application of spironolactone in man For men who want the DHT-blocking benefit at the scalp without the gynecomastia and sexual side effects of oral therapy, topical formulations are an appealing option. Availability varies by country, and some formulations are compounded by specialty pharmacies rather than sold as standard products.
Spironolactone in Feminizing Hormone Therapy
Outside of the typical medical indications, spironolactone is one of the most commonly used antiandrogens in feminizing hormone regimens for transgender women in the United States. In this setting, the antiandrogenic effects are not side effects but the whole point. The drug is typically used alongside estradiol to suppress the effects of testosterone and promote feminization.25PubMed Central. Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations
One reassuring piece of data from this population: a retrospective study of primarily middle-aged transgender women on spironolactone found that while mean potassium levels did rise slightly after a median of about two years on the drug, not a single patient exceeded the upper limit of the normal reference range.26Endocrine Practice. Potassium Concentrations in Transgender Women Using Spironolactone: A Retrospective Chart Review This is a relatively healthy population compared to the heart failure and cirrhosis patients who make up most of the other research, so the lower hyperkalemia risk makes sense. It does not mean monitoring can be skipped, but it suggests that the potassium concern is most urgent in people who already have compromised kidney function or are on other potassium-raising medications.
What Determines Whether the Side Effects Hit You
Not every man on spironolactone develops gynecomastia or sexual side effects, and the variability matters for practical decision-making. Dose is the single biggest factor. The breast and sexual changes are clearly dose-dependent: a man on 25 mg per day for heart failure is at much lower risk than a man on 200 or 400 mg per day for ascites. Duration matters too, as illustrated by the case report where gynecomastia appeared after 12 months of continuous use. Age and baseline hormonal status also play a role, though these are harder to pin down from the available research.
If you are starting spironolactone, there is no reliable way to predict in advance whether you will be among those who develop significant hormonal side effects. The practical approach most clinicians follow is to start at the lowest effective dose, monitor for symptoms, and have a plan for switching to eplerenone or adjusting the dose if problems develop. Men who notice breast tenderness, swelling, or changes in sexual function should report these early rather than waiting, since the effects are generally reversible if the drug is stopped or switched promptly. Waiting months while hoping the symptoms resolve on their own typically just extends the discomfort.
Kidney function is the other individual factor that matters most, not for the hormonal effects, but for the hyperkalemia risk. If your kidneys are not clearing potassium efficiently, even a low dose of spironolactone can push levels into a concerning range. Older men, men with diabetes, and men with any degree of chronic kidney disease fall into a higher-risk category and should expect more frequent blood draws, especially in the first few months.